This inventor holds 3 USPTO granted patents and 2 published patent applications. Top assignee: Ono Pharmaceutical Co., Ltd.. Active years: 2021-2024.
Company Filing History:
Years Active: 2021-2024
Title: Kenichi Kouda: Innovator in Cancer and Infectious Disease Treatment
Introduction
Kenichi Kouda is a prominent inventor based in Osaka, Japan. He has made significant contributions to the field of pharmaceuticals, particularly in the development of innovative compounds for treating cancer and infectious diseases. With a total of three patents to his name, Kouda's work is paving the way for new therapeutic options.
Latest Patents
Kouda's latest patents include a STING agonistic compound, which is a drug or agent containing a compound that exhibits agonistic activity to STING as an active ingredient. The compound is represented by a specific general formula, where all symbols have defined meanings as described in the specification. This compound can be utilized as an active ingredient in agents aimed at suppressing the progression, recurrence, and treatment of cancer or infectious diseases.
Career Highlights
Throughout his career, Kenichi Kouda has been associated with Ono Pharmaceutical Co., Ltd., a leading company in the pharmaceutical industry. His work has focused on developing innovative solutions that address critical health challenges.
Collaborations
Kouda has collaborated with notable colleagues, including Ryosuke Hanada and Masaya Kokubo. These partnerships have contributed to the advancement of research and development in the pharmaceutical sector.
Conclusion
Kenichi Kouda's contributions to the field of pharmaceuticals, particularly through his innovative patents, highlight his commitment to improving health outcomes. His work continues to inspire advancements in cancer and infectious disease treatment.